The two big bullish catalysts for biotech stocks

The XBI biotech ETF has surged 49 percent in 2017 to its highest level in more than two years. Some say the move isn't over just yet.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.